Clinical Drug Experience Knowledgebase

Adenocarcinoma (Phase 3)

Anemia (Phase 2)

Anemia, Refractory (Phase 3)

Anemia, Refractory, with Excess of Blasts (Phase 3)

Carcinoma (Phase 2)

Carcinoma, Hepatocellular (Phase 1)

Carcinoma, Ovarian Epithelial (Phase 2)

Carcinoma, Squamous Cell (Phase 2)

Epidermolysis Bullosa (Phase 1)

Epidermolysis Bullosa Dystrophica (Phase 1)

Esophageal Squamous Cell Carcinoma (Phase 2)

Head and Neck Neoplasms (Phase 1)

Leukemia (Phase 2)

Leukemia, Lymphocytic, Chronic, B-Cell (Phase 1)

Leukemia, Lymphoid (Phase 2)

Leukemia, Myelogenous, Chronic, BCR-ABL Positive (Phase 2)

Leukemia, Myeloid (Phase 2)

Leukemia, Myeloid, Acute (Phase 2)

Leukemia, Myelomonocytic, Chronic (Phase 3)

Leukemia, Myelomonocytic, Juvenile (Phase 3)

Liver Neoplasms (Phase 1)

Lymphoma (Phase 1)

Myelodysplastic Syndromes (Phase 3)

Myeloproliferative Disorders (Phase 2)

Neoplasms (Phase 1)

Ovarian Neoplasms (Phase 2)

Pancreatic Neoplasms (Phase 3)

Precursor Cell Lymphoblastic Leukemia-Lymphoma (Phase 2)

Preleukemia (Phase 3)

Primary Myelofibrosis (Phase 2)

Splenomegaly (Phase 2)

Squamous Cell Carcinoma of Head and Neck (Phase 2)

Syndrome (Phase 3)

Trisomy (Phase 2)